Stepien et al., 2023 - UK consensus
Burlina et al., 2023 - Biomarkers for Fabry Disease
Wanner et al., 2018 - European consensus on therapeutic goals
Ortiz et al., 2018 - Expert consensus on management of adult patients
Germain et al., 2019 - Expert consensus on management of children
Diretrizes Brasileiras - Brazilian public health system guidelines for diagnosis and treatment of Fabry disease
Généo, 2021 - Treatment protocol of the French Fabry Disease Reference Center.
Sirrs et al., 2018 - Canadian Protocol
Australian Government - Australian government criteria for initiation and renewal of treatment with agalsidase alfa, agalsidase beta and migalastat.